Below are the most recent publications written about "Analgesics, Opioid" by people in Profiles.
-
Beltran NM, Sullivan LL, Naime GM, Minervini V, Serafine KM. Eating a high fat/high carbohydrate diet enhances morphine tolerance, while eating a ketogenic diet mitigates morphine withdrawal in male rats. Eur J Pharmacol. 2025 Aug 05; 1000:177709.
-
Beltran NM, Garcia TI, Naime GM, Minervini V, Serafine KM. The effects of high fat diet consumption on morphine-induced constipation. Behav Pharmacol. 2025 Aug 01; 36(5):343-346.
-
Syvertsen J, Cabral A, Knaap E, Rey S, Pollini RA. The emergence of fentanyl in a stimulant landscape: Un/intentional use, social relations, and developing communities of care. Int J Drug Policy. 2025 Jun; 140:104807.
-
Lovett K, Zatzick D, Palinkas LA, Engstrom A, Nye E, Field C, McGovern M, Parrish C, Banta-Green CJ, Whiteside LK. Adapting to the Fentanyl Epidemic: Rapid Qualitative Observations and Derived Clinical and Research Implications from the Emergency Department Longitudinal Integrated Care (ED-LINC) Randomized Clinical Trial. Psychiatry. 2025; 88(4):333-350.
-
Marshall-Lipiec SM, Ryan KL, Calderon ML, Rodriguez CM, Connor BS, Hinojosa-Laborde C, Klemcke HG. Effects of analgesic doses of opioids on cardiorespiratory responses and survival to hemorrhage and trauma in rats. J Appl Physiol (1985). 2025 Jul 01; 139(1):145-161.
-
Bernstein CN, Fisk JD, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Graff LA, Marrie RA. Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population. Inflamm Bowel Dis. 2025 Feb 10; 31(2):386-393.
-
Sharafshah A, Lewandrowski KU, Elman I, Baron D, Thanos PK, Hanna C, Gold MS, Badgaiyan RD, Cadet JL, Modestino EJ, Braverman ER, Dennen CA, Makale M, Sunder K, Murphy KT, Bowirrat A, Pinhasov A, Gondre-Lewis M, Gardner E, Sipple D, Jafari N, Zeine F, Khalsa J, Fiorelli RKA, Blum K. A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era. Curr Pharm Biotechnol. 2025; 26(13):2153-2180.
-
Dicker F, Lothet E, Schwarz E, Aldy K, Brent J, Wax P, Culbreth R, Campleman S, Krotulski A, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Hendrickson RG, Meaden CW, Manini AF. Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohort. Am J Emerg Med. 2025 Mar; 89:169-173.
-
Broussard G, Hohmeier KC, Field C, Gordon AJ, Carlston K, Cernasev A, Tyszko M, Snyder AM, Cochran G. Barriers and facilitators to the implementation of screening and intervention for co-use of opioid medications and alcohol among community pharmacy patients. J Subst Use Addict Treat. 2025 Feb; 169:209606.
-
Balise RR, Hu MC, Calderon AR, Odom GJ, Brandt L, Luo SX, Feaster DJ. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLoS One. 2024; 19(11):e0312695.